CTM Form 4: Director granted 100,000 options; 20‑month vesting
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Castellum, Inc. (CTM) disclosed an insider equity award. Director Bernard S. Champoux was granted 100,000 stock options on 11/11/2025 with an exercise price of $1.19 per share under the Second Amended 2021 Stock Incentive Plan. The options vest ratably over twenty months starting December 1, 2025 and expire on 11/10/2032. The filing lists ownership as Direct (D). This is a routine compensation grant to a board member, not an open‑market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Champoux Bernard S
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 100,000 | $0.00 | -- |
Holdings After Transaction:
Stock Options — 100,000 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Castellum (CTM) disclose in this Form 4?
A director, Bernard S. Champoux, received 100,000 stock options on 11/11/2025 at an exercise price of $1.19.
What are the vesting terms of the CTM director’s options?
They vest ratably over twenty months beginning December 1, 2025.
When do the granted CTM options expire?
The options expire on 11/10/2032.
What is the ownership form reported for the options?
The filing reports Direct (D) ownership.
Under which plan were the CTM options granted?
They were granted under the Second Amended 2021 Stock Incentive Plan.
Is this a market transaction or compensation grant?
It is a compensation grant, not an open‑market purchase or sale.